BELLONE, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 1.723
AS - Asia 685
EU - Europa 416
SA - Sud America 137
Continente sconosciuto - Info sul continente non disponibili 45
AF - Africa 11
OC - Oceania 2
AN - Antartide 1
Totale 3.020
Nazione #
US - Stati Uniti d'America 1.681
SG - Singapore 232
CN - Cina 230
UA - Ucraina 117
BR - Brasile 111
HK - Hong Kong 69
IT - Italia 62
DE - Germania 55
FI - Finlandia 52
VN - Vietnam 52
FR - Francia 29
CA - Canada 28
IN - India 24
TR - Turchia 24
GB - Regno Unito 20
IE - Irlanda 18
RU - Federazione Russa 16
BD - Bangladesh 15
AR - Argentina 13
MX - Messico 8
ID - Indonesia 7
NL - Olanda 7
PL - Polonia 7
SE - Svezia 6
EC - Ecuador 5
JP - Giappone 5
ES - Italia 4
IQ - Iraq 4
LT - Lituania 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AT - Austria 3
BE - Belgio 3
CZ - Repubblica Ceca 3
KG - Kirghizistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
PK - Pakistan 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MY - Malesia 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 2.975
Città #
Fairfield 180
Woodbridge 158
Ashburn 152
Singapore 134
Houston 113
Jacksonville 76
Wilmington 72
Ann Arbor 68
Hong Kong 68
Seattle 67
Cambridge 62
New York 59
San Jose 51
Beijing 45
Dearborn 43
Nanjing 34
Helsinki 33
Los Angeles 33
Chandler 32
Princeton 30
Indianapolis 27
The Dalles 25
Ho Chi Minh City 20
Istanbul 18
Dublin 17
Lauterbourg 16
Orem 16
Chicago 15
Council Bluffs 15
Shanghai 15
Hanoi 13
San Francisco 13
Santa Clara 12
São Paulo 12
Toronto 12
Columbus 11
Denver 11
Moscow 11
Shenyang 11
Des Moines 10
Munich 10
Chennai 8
Milan 8
Montreal 8
Nanchang 8
San Diego 8
Dallas 7
Kunming 7
Redondo Beach 7
Belo Horizonte 6
Buffalo 6
Mooresville 6
Rome 6
Warsaw 6
Amsterdam 5
Atlanta 5
Brooklyn 5
Hebei 5
Jiaxing 5
Jinan 5
Ningbo 5
Paris 5
Tianjin 5
Tokyo 5
Boston 4
Brescia 4
Charlotte 4
Da Nang 4
Mumbai 4
Nuremberg 4
Stockholm 4
Turku 4
Arezzo 3
Bishkek 3
Brasília 3
Brussels 3
Changsha 3
Guangzhou 3
Guarulhos 3
Hangzhou 3
Hefei 3
Kilburn 3
London 3
Monmouth Junction 3
Pelotas 3
Querétaro 3
Amman 2
Auburn Hills 2
Baghdad 2
Baku 2
Bismarck 2
Biên Hòa 2
Boardman 2
Catanduva 2
Chongqing 2
City of London 2
Dammam 2
Diadema 2
Frankfurt am Main 2
Greenville 2
Totale 2.063
Nome #
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 238
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 213
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 205
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 192
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. 188
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 185
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab. 171
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 167
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 167
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 165
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 160
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2) 150
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. 149
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 148
Serum amyloid A: a novel biomarker for endometrial cancer. 124
Integrated mutational landscape analysis of uterine leiomyosarcomas 119
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 97
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 90
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 90
Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody. 2
Totale 3.020
Categoria #
all - tutte 12.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 34 0 2 1 11 11 6 4 22 14 26
2022/2023138 22 3 3 6 13 27 5 16 18 0 13 12
2023/2024173 13 11 20 4 8 38 13 5 33 6 1 21
2024/2025307 1 4 2 37 22 37 20 7 38 23 76 40
2025/2026958 94 93 74 199 120 59 155 21 44 59 26 14
2026/202759 34 25 0 0 0 0 0 0 0 0 0 0
Totale 3.020